Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States.
Wei-Hsuan Lo-CiganicJulie M DonohueJoo Yeon KimElizabeth E KransBobby L JonesDavid KelleyAlton E JamesMarian P JarlenskiPublished in: Pharmacoepidemiology and drug safety (2018)
Six buprenorphine treatment trajectories during pregnancy were identified in this population-based Medicaid cohort, with 25% of women initiating buprenorphine late during pregnancy. Understanding trajectories of buprenorphine use and factors associated with discontinuation/nonadherence may guide integration of behavioral treatment with obstetrical/gynecological care to improve buprenorphine treatment during pregnancy.